Compositions and methods for the treatment of meibomian gland dysfunction
AssigneeAzura Ophthalmics Ltd.
InventorsYair Alster, Omer Rafaeli, Kirsten Angela Macfarlane, Cary Reich, Shimon Amselem, Doron Friedman
Life of this patent
Estimating the term…
Abstract
Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said compositions and methods comprise keratolytic agents, such as salicylic acid, selenium disulfide, or the like. Topical administration of said compositions to the eyelid margin or surrounding areas provides therapeutic benefit to patients suffering from meibomian gland dysfunction.
Claims20
A method for opening a meibomian gland obstruction or improving the quality of meibum in an individual in need thereof, the method comprising topically administering to the eyelid of a subject a composition comprising a keratolytic agent and an ophthalmically or pharmaceutically acceptable vehicle or carrier, the composition being administered to the eyelid of the individual in a manner suitable to deliver the keratolytic agent to an eyelid margin of the individual.
Dependencies are inferred from the claim text.